Stratatech Corp., a Madison company developing skin tissue products to treat burn victims, will be purchased by Mallinckrodt Pharmaceuticals, a specialty pharmaceutical company based in the United Kingdom....
Arrowhead Pharmaceuticals — a California drug development company with most of its operations in Madison — plans to raise $45 million in a private stock offering....
Imbed Biosciences, located at University Research Park, received clearance from the FDA to market its Microlyte Ag wound dressing for prescription and over-the-counter use. ...
Biotech has been one of the hottest sectors in the venture capital asset class over the past few years. Strong IPO and M&A markets have put wind in the sails of the space since 2012, and robust investment activity has enabled a wave of well-funded...
FluGen, a Madison biotechnology company that is developing flu vaccines, has begun a clinical trial of its RedeeFlu universal influenza vaccine....
Invenra's cell-free protein expression technology allows for the screening of hundreds of thousands of full antibodies, and is much faster than conventional cell-based methods for finding therapeutic antibodies....
WARF's new managing director, Erik Iverson takes the helm of the Wisconsin Alumni Research Foundation as the 91-year-old organization is hitting a major “inflection point.” ...
Madison's growing startup sector is positively impacting industry outside of the entrepreneurial ecosystem....
The use of Cologuard, the home-based stool test by Madison-based Exact Sciences, could be included in how doctors and clinics are evaluated for colorectal cancer screening nationally, which might prompt more use of the test, the company said Wednesday....
Rather than focus solely on established businesses, Madison Chamber president Zach Brandon has embraced startups and "scalable and salable" companies as the future....